» Articles » PMID: 1698386

Dipeptidyl Peptidase IV in the Immune System. Cytofluorometric Evidence for Induction of the Enzyme on Activated T Lymphocytes

Overview
Specialty Biochemistry
Date 1990 Aug 1
PMID 1698386
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Dipeptidyl peptidase IV (DP IV) is a membrane peptidase with essential functional significance in thymus derived lymphocytes. This conclusion is drawn from 1) the induction of this enzyme after stimulation of T lymphocytes in vitro and 2) the impairment of T cell functions in presence of active site-specific inhibitors of the enzyme. The first item will be addressed in this paper, whereas the second one will be treated in a forthcoming article. Using flow cytofluorometry we investigated the expression of dipeptidyl peptidase IV on activated lymphocytes and the phenotype of lymphocytes expressing this enzyme. After stimulation by mitogenic lectins the number of epitopes on the cell surface binding polyclonal antibodies against DP IV increases 4 to 6 times. By means of double fluorescence staining the enzyme has been shown to be restricted nearly exclusively to T lymphocytes even after mitogenic stimulation. The highest density of DP IV epitopes has been found in cells coexpressing activation markers like receptors for interleukin 2 or transferrin in a high density.

Citing Articles

Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.

Wolke C, Teumer A, Endlich K, Endlich N, Rettig R, Stracke S Exp Biol Med (Maywood). 2017; 242(5):554-563.

PMID: 28038565 PMC: 5367655. DOI: 10.1177/1535370216684040.


The Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including Atherosclerosis.

Waumans Y, Baerts L, Kehoe K, Lambeir A, De Meester I Front Immunol. 2015; 6:387.

PMID: 26300881 PMC: 4528296. DOI: 10.3389/fimmu.2015.00387.


Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver.

Chowdhury S, Chen Y, Yao T, Ajami K, Wang X, Popov Y World J Gastroenterol. 2013; 19(19):2883-93.

PMID: 23704821 PMC: 3660813. DOI: 10.3748/wjg.v19.i19.2883.


Successful immunomodulating in AIDS patients with ursodeoxycholic acid--a pilot study.

Kurktschiev D, Temelkova-Kurktschiev T, Horn K, Schentke K Clin Exp Immunol. 1999; 115(1):144-6.

PMID: 9933434 PMC: 1905196. DOI: 10.1046/j.1365-2249.1999.00760.x.


Neuropeptide degrading enzymes in normal and inflamed human synovium.

Walsh D, Mapp P, Wharton J, Polak J, Blake D Am J Pathol. 1993; 142(5):1610-21.

PMID: 8098586 PMC: 1886899.